"When I was about 28, I was like; 'I've had enough'. I demanded that I see a gynaecologist or I would go to the complaints ...

I kept bringing up endometriosis… for years and years I begged doctors because I knew it wasn't gastro. “When I was about 28, ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...

Jefferies lowered the firm’s price target on Bicycle Therapeutics (BCYC) to $42 from $53 and keeps a Buy rating on the shares. For the FY24 ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...

(Reuters) - Johnson & Johnson (NYSE: JNJ) sued Samsung (KS: 005930) Bioepis for allegedly breaching a contract agreement over ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

The company, along with its subsidiary NTPC Green Energy, has entered into multiple MoUs with the Madhya Pradesh government ...

A British study found that virtual chromoendoscopy has a higher neoplasia detection rate than other endoscopic modalities ...